JuanFernandoGallegos-OrozcoMDAGAF

Gastroenterology • Salt Lake City, UT

Hepatology & Liver Transplantation

Associate Professor of Medicine Medical Director of Liver Transplant

Join to view full profile

Dr. Gallegos-Orozco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gallegos-Orozco's full profile

Already have an account?

Office
50 N Medical Dr
Salt Lake City, UT 84132
Phone+1 801-581-7802

Fax+1 801-585-3655

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2011 - 2012
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2009 - 2011
Mayo Clinic College of Medicine and Science (Scottsdale)Residency, Internal Medicine, 2006 - 2009
Universidad Nacional Autonoma de MexicoClass of 1995

Certifications & Licensure

UT State Medical License 2012 - 2026
ID State Medical License 2021 - 2025
NV State Medical License 2021 - 2025
WY State Medical License 2021 - 2025
CO State Medical License 2021 - 2023
MT State Medical License 2021 - 2023
AZ State Medical License 2010 - 2022
FL State Medical License 2009 - 2012
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology
Join now to see all

Clinical Trials

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Completed
Phase 3
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis Start of enrollment: 2013 Aug 01
Completed
Phase 2
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC Start of enrollment: 2019 Jun 20
Recruiting
Phase 1
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs Start of enrollment: 2021 Jul 08
Recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

57 citations
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension.
Guadalupe Garcia-Tsao, Michael Fuchs, Mitchell L. Shiffman, Brian B. Borg, Nikolaos Pyrsopoulos
Hepatology. 2019-02-01
52 citations
Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21‐hydroxylase (CYP21A2) d...
M. Mercè Fernández-Balsells, Kalpana Muthusamy, Galina Smushkin, Julianna F. Lampropulos, Mohamed B. Elamin
Clinical Endocrinology. 2010-10-01
33 citations
Complex colon polypectomy
Juan F. Gallegos-Orozco, Suryakanth R. Gurudu
Gastroenterology & Hepatology. 2010-06-01

Press Mentions

NASH – A Silent Killer: 150 World Experts Sign a Global Call to Action to Promote Awareness of Deadly Liver DiseaseJune 5th, 2018